These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Meddi P, Merli M, Lionetti R, De Santis A, Valeriano V, Masini A, Rossi P, Salvatori F, Salerno F, de Franchis R, Capocaccia L, Riggio O. Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949 [Abstract] [Full Text] [Related]
24. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. Yu J, Wang X, Jiang M, Ma H, Zhou Z, Yang L, Li X. Eur Radiol; 2019 Feb; 29(2):699-706. PubMed ID: 30039223 [Abstract] [Full Text] [Related]
25. [Intrahepatic portasystemic shunt and hemorrhagic emergencies in the cirrhotic patient]. Perarnau JM, Mrani-Alaoui MS, Magnin F, Sarkis M, Raabe JJ, Arbogast J. Ann Chir; 1995 Feb; 49(7):580-6; discussion 587-8. PubMed ID: 8554268 [Abstract] [Full Text] [Related]
27. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, Girard B, Orloff KJ. Surgery; 2015 Jun; 157(6):1028-45. PubMed ID: 25957003 [Abstract] [Full Text] [Related]
28. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization. Schultheiß M, Giesler M, Maruschke L, Schmidt A, Sturm L, Thimme R, Rössle M, Bettinger D. Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517 [Abstract] [Full Text] [Related]
29. Emergency transjugular intrahepatic portosystemic shunt in patients with active variceal bleeding and hepatocarcinoma. Mingoli A, Modini C, Salvatori F, Bezzi M, Sgarzini G, Nardacchione F, Marzano M. Ital J Gastroenterol; 1995 May; 27(6):309-12. PubMed ID: 8562997 [Abstract] [Full Text] [Related]
34. TIPS (transjugular intrahepatic portosystemic shunt): state of art and personal experience. Ugolotti U, Larini P, Marcato C, Saccani A, Pedretti G. Acta Biomed Ateneo Parmense; 1996 Jul; 67(3-4):143-9. PubMed ID: 10021697 [Abstract] [Full Text] [Related]
35. Transjugular intrahepatic porto-systemic stent-shunt for therapy of bleeding esophageal varices due to extramedullary hematopoiesis in primary myelofibrosis: a case report. Phillip V, Berger H, Straub M, Saugel B, Treiber M, Einwächter H, Schmid RM, Huber W. Onkologie; 2012 Jul; 35(6):368-71. PubMed ID: 22722458 [Abstract] [Full Text] [Related]
38. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Barrio J, Ripoll C, Bañares R, Echenagusia A, Catalina MV, Camúñez F, Simó G, Santos L. Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109 [Abstract] [Full Text] [Related]
39. Safety and efficacy of TIPS in patients with hemophilia and cirrhosis. Beirne JP, Bloom AI, Bass NM, Kerlan RK, Wilson MW, Gordon RL, Laberge JM. J Vasc Interv Radiol; 2007 Feb; 18(2):309-12. PubMed ID: 17327567 [Abstract] [Full Text] [Related]